Skip to main content

Table 2 Results of nonparametric linkage analysis of genome-wide scanning with LOD score ≥ 1.5 (if two or more adjacent markers, only the one with the highest score listed).

From: Sibling recurrence risk ratio analysis of the metabolic syndrome and its components over time

Trait

Cross-Sectional Diagnosis Marker (LOD)

Lifetime Diagnosis

  

Episode ≥ 1 Marker (LOD)

Episode ≥ 2 Marker (LOD)

Episode ≥ 3 Marker (LOD)

Hypertension

-

C1g32 (1.6)

C1g32 (1.6)

C1g32 (1.6)

  

C17g2 (2.1)

C9g11 (1.7)

C9g11 (1.7)

  

C22g1 (1.5)

C22g1 (1.5)

C22g1 (1.5)

Obesity (high BMI)

-

-

C8g10 (1.5)

C8g10 (1.5)

 

-

C12g3 (1.5)

-

-

 

-

C19g11 (1.5)

-

-

Hyperglycemia

-

C3g26 (1.5)

-

-

 

-

C8g10 (1.5)

-

-

 

-

C10g8 (1.5)

-

-

Hypertriglyceridemia

-

C6g8 (1.8)

-

-

 

C10g12 (1.5)

C10g12 (1.6)

-

-

 

-

C13g9 (1.5)

C13g9 (1.5)

C13g9 (1.5)

 

-

C17g2 (1.9)

-

-

 

C22g7 (1.5)

C22g7 (1.5)

C22g7 (1.5)

-

Low HDL cholesterol

 

C9g7 (2.0)

-

-

 

C10g11 (1.5)

-

C10g12 (1.8)

C10g12 (1.6)

 

-

C12g3 (1.8)

-

-

 

-

-

C13g8 (1.5)

C13g8 (1.5)

 

-

C16g3 (1.9)

-

-

 

-

-

C18g9 (1.8)

-

 

C19g3 (1.8)

C19g3 (2.4)

-

-

 

-

-

C22g7 (1.8)

-

Metabolic syndrome

-

C9g12 (1.5)

NAA

NA

 

-

C10g2 (1.5)

  
 

-

C12g3 (1.5)

  
 

-

C19g8 (2.0)

  
 

-

C22g7 (2.2)

  
  1. ANot done because many subjects did not have complete information on all five components.